PECARN Rule for Low Risk Febrile Infants (8–60 Days)

Learn how the PECARN Rule for Low Risk Febrile Infants 8-60 Days Old calculator works, including urinalysis, ANC, procalcitonin criteria, and interpretation in well-appearing febrile infants.

PECARN low-risk assessment (laboratory rule)

Enter age and laboratory values for a previously healthy, non–critically ill febrile infant who meets the original study inclusion criteria. Low risk requires all three criteria: negative urinalysis, ANC ≤ 4,090 /µL, and procalcitonin ≤ 1.71 ng/mL.

Age (days)

Use chronological age in days. The published rule was derived in infants 60 days and younger; this calculator follows an 8–60 day window aligned with many ED pathways. Extra caution applies at 28 days or below (see results text).

Absolute neutrophil count (ANC, cells/µL)

Serum procalcitonin (ng/mL)

Disclaimer: This calculator is for education only. It does not replace bedside assessment, viral or HSV testing when indicated, institutional pathways, or clinician judgment. The parent study excluded critically ill infants, recent antibiotics, very preterm birth (≤26 weeks), major comorbidity, devices, and certain infections; the rule should not be applied outside a similar population.

PECARN febrile infant rule: variables, interpretation, and context

Overview

Kuppermann et al. derived and validated a three-variable laboratory rule to identify febrile infants 60 days of age and younger at low risk for serious bacterial infection (SBI), defined as urinary tract infection, bacteremia, or bacterial meningitis. The rule uses urinalysis, absolute neutrophil count (ANC), and serum procalcitonin. When all three criteria are satisfied, the validation cohort showed high sensitivity and negative predictive value for SBI. This implementation follows the published thresholds and UA definition; compare with MDCalc and the primary literature for full nuance.

Low-risk laboratory criteria (all required)

The infant is classified as low risk by this rule only if every row below is satisfied.

Variable	Low-risk threshold
Urinalysis	"Negative": no positive leukocyte esterase (including trace), no positive nitrite, and not more than 5 WBC per high-power field
ANC	≤ 4,090 cells/µL
Serum procalcitonin	≤ 1.71 ng/mL

Study population and exclusions

Eligible infants had fever (rectal temperature ≥ 38°C in the ED, another setting, or at home within 24 hours), were 60 days old or younger, and had blood cultures obtained. Major exclusions included critically ill appearance, antibiotics in the prior 48 hours, gestational age ≤ 26 weeks, pre-existing medical conditions, indwelling devices, and soft tissue infection. Otitis media alone did not exclude enrollment. Viral testing was not part of the model; herpes simplex was not specifically captured. Many educators emphasize extra caution when applying any SBI risk tool to infants about 28 days old or younger.

Reported test characteristics

In the validation analysis reported in the primary publication, meeting all three criteria was associated with approximately 97.7% sensitivity for SBI, about 60% specificity, negative predictive value about 99.6%, and negative likelihood ratio about 0.04. Performance in a new setting depends on disease prevalence, lab quality, and whether patients resemble the trial cohort.

UTI definition in the parent study

UTI was defined by culture thresholds (including catheterized samples at 50,000 CFU/mL or greater, or 10,000 to 50,000 CFU/mL with an abnormal urinalysis, and lower thresholds for suprapubic aspiration). This can make the rule behave conservatively relative to some guideline UTI definitions.

Why this calculator uses 8–60 days

The original paper enrolled infants up to 60 days. Many emergency departments align operational pathways with febrile infant guidance that emphasizes infants from about 8 through 60 days when discussing outpatient risk stratification; younger febrile neonates often receive a different default workup. This tool therefore asks for age in that window and adds explicit language for infants 28 days old or younger.

Primary reference

Kuppermann N, Dayan PS, Levine DA, et al. A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections. JAMA Pediatr. 2019;173(4):342-351. PMID: 30776077.

PECARN Rule for Low Risk Febrile Infants 8-60 Days Old

The PECARN Rule for Low Risk Febrile Infants 8-60 Days Old is a clinical prediction tool used to help identify well-appearing young infants with fever who are at lower risk for serious bacterial infection. In real clinical practice, fever in a very young infant can be difficult to evaluate because even a well-appearing baby may still have a urinary tract infection, bacteremia, or, less commonly, bacterial meningitis. For that reason, structured risk-stratification tools are important.

A PECARN febrile infant calculator is generally used to determine whether a febrile infant meets the laboratory profile associated with a lower likelihood of serious bacterial infection. The classic PECARN low-risk rule is based on three laboratory findings: a negative urinalysis, an absolute neutrophil count of 4090/µL or less, and a procalcitonin level of 1.71 ng/mL or less. If all of these criteria are satisfied in the appropriate clinical setting, the infant may be considered low risk by the PECARN rule.

It is important to understand that this rule is not a diagnosis by itself and not a guarantee that infection is absent. Instead, it helps clinicians estimate risk more accurately and decide how aggressively to pursue lumbar puncture, hospitalization, antibiotic treatment, and other aspects of evaluation.

Why Febrile Infants Need Special Evaluation

Infants in the first two months of life are different from older children. Their immune systems are still immature, symptoms may be subtle, and serious infections can progress quickly. A newborn or young infant with fever may look relatively calm and well at first but still harbor an invasive bacterial infection.

Because of this, febrile infants have traditionally been evaluated more aggressively than older children with fever. However, not every infant needs the same degree of testing or admission. The challenge is identifying which infants are at higher risk and which are at sufficiently low risk that a less invasive approach may be reasonable. The PECARN rule helps address that challenge.

What the PECARN Rule Is Designed to Predict

The original PECARN rule was developed to identify febrile infants aged 60 days and younger who were at low risk for serious bacterial infection, often abbreviated as SBI. In this context, serious bacterial infection mainly includes:

Urinary tract infection
Bacteremia
Bacterial meningitis

Among these, bacteremia and meningitis are especially concerning because they are forms of invasive bacterial infection. The PECARN rule is useful because it tries to identify infants in whom the likelihood of these major infections is low enough to support more selective management.

Which Infants the Rule Applies To

The PECARN febrile infant framework is generally discussed in the setting of:

Infants 8 to 60 days old
Well-appearing infants
Documented fever, usually rectal temperature of 38.0°C (100.4°F) or higher
Previously healthy, term infants

This is important because the rule is not intended for every infant with fever. It is not designed for toxic-appearing infants, markedly premature infants, infants with major congenital abnormalities, known immunodeficiency, recent antibiotic exposure that alters evaluation, or infants whose clinical condition clearly demands more aggressive treatment regardless of prediction rules.

The Three PECARN Low-Risk Criteria

The PECARN low-risk rule is built around three key laboratory findings. A febrile infant is considered low risk by the rule when all three are present:

Negative urinalysis
Absolute neutrophil count (ANC) 4090/µL or less
Procalcitonin 1.71 ng/mL or less

Each of these findings contributes different information about the infant’s risk of bacterial infection.

1. Negative urinalysis

A negative urinalysis lowers concern for urinary tract infection, which is the most common serious bacterial infection in febrile infants. Because urinary tract infection is common in this age group, urine testing is a major part of risk stratification. If the urinalysis is positive or suggestive of infection, the infant does not meet PECARN low-risk criteria.

2. Absolute neutrophil count 4090/µL or less

The absolute neutrophil count, or ANC, is a blood test value that reflects the number of circulating neutrophils, a type of white blood cell involved in bacterial infection and inflammation. Higher ANC values can be associated with bacterial infection. In the PECARN rule, an ANC of 4090/µL or less is the threshold for the low-risk category.

3. Procalcitonin 1.71 ng/mL or less

Procalcitonin is an inflammatory biomarker that often rises in bacterial infections and may be more helpful than older lab markers in distinguishing bacterial from viral illness in very young infants. In the PECARN rule, a procalcitonin value of 1.71 ng/mL or less is part of the low-risk profile.

How the PECARN Rule Is Calculated

The PECARN rule is not a point-based score like many other calculators. It works more like a yes-or-no checklist.

A PECARN calculator typically asks whether the following are all true:

Urinalysis is negative
ANC is 4090/µL or less
Procalcitonin is 1.71 ng/mL or less

If the answer is yes to all three, the infant meets the low-risk criteria. If any one of the three is abnormal, the infant does not meet the PECARN low-risk rule.

How to Interpret the Result

The result of the PECARN calculator is usually presented in a simple way:

Meets PECARN low-risk criteria
Does not meet PECARN low-risk criteria

This type of output is appropriate because the rule is intended to support a clinical pathway rather than generate a broad severity score.

If the infant meets the low-risk criteria, the likelihood of serious bacterial infection is lower, and clinicians may consider a less invasive or less aggressive management strategy, depending on the infant’s age group and the local protocol. If the infant does not meet the criteria, the infant is not considered low risk by PECARN, and more complete evaluation is usually warranted.

Why the Rule Uses These Specific Tests

The PECARN investigators selected these markers because they performed well in distinguishing low-risk from higher-risk febrile infants. Each test captures a different part of the evaluation:

Urinalysis screens for urinary tract infection
ANC reflects part of the systemic inflammatory response
Procalcitonin helps detect bacterial infection with better specificity than many traditional markers alone

Using them together allows a more refined assessment than relying on appearance alone or on a single laboratory test.

Role of Procalcitonin in the PECARN Rule

One of the most important features of the PECARN rule is its use of procalcitonin. Earlier febrile infant approaches often relied more heavily on total white blood cell count, band count, or other markers that are less precise. The PECARN model was important because it showed that procalcitonin, combined with ANC and urinalysis, could help identify a low-risk group more accurately.

This is also why some older fever algorithms and the PECARN rule should not be treated as interchangeable. If a clinician is specifically using the PECARN rule, procalcitonin is part of the classic low-risk definition.

Age Matters Even Within the 8-60 Day Group

Although this article discusses the rule under the broad heading of 8 to 60 days, age within that range still matters clinically. An infant who is 10 days old is not managed the same way as an infant who is 45 days old, even if both have the same laboratory profile.

In modern febrile infant pathways, especially those informed by AAP guidance, management decisions are usually divided into smaller age groups such as:

8 to 21 days
22 to 28 days
29 to 60 days

That means the PECARN low-risk rule should be interpreted within the broader age-specific management framework. Meeting low-risk criteria does not always mean the same thing for a 9-day-old infant as it does for a 45-day-old infant.

Example 1: Infant Who Meets Low-Risk Criteria

A 35-day-old well-appearing infant presents with rectal fever. The evaluation shows:

Urinalysis negative
ANC 3200/µL
Procalcitonin 0.4 ng/mL

This infant meets all three PECARN low-risk criteria and would be classified as low risk by the rule. The next clinical step would still depend on the infant’s age, local protocol, and physician judgment, but the laboratory risk profile is reassuring.

Example 2: Infant Who Does Not Meet Low-Risk Criteria Because of Urine Findings

A 42-day-old well-appearing infant has fever, an ANC of 2800/µL, and procalcitonin of 0.3 ng/mL, but the urinalysis is positive for findings concerning for urinary infection.

This infant does not meet PECARN low-risk criteria because the urinalysis is not negative. Since urinary tract infection is a major serious bacterial infection in this age group, the positive urine result is enough to remove the infant from the low-risk group.

Example 3: Infant Who Does Not Meet Low-Risk Criteria Because of Inflammatory Markers

A 50-day-old well-appearing infant has a negative urinalysis, but the ANC is 5600/µL. Even if the procalcitonin is low, this infant still does not meet the PECARN rule because all three criteria must be satisfied.

Why the Rule Is Useful

The PECARN rule is useful because it helps reduce unnecessary invasive testing and hospitalization in selected febrile infants while preserving safety. Not every infant with fever needs the same workup. By identifying a lower-risk subgroup, clinicians may be able to individualize care more appropriately.

The rule is especially valuable because:

It is based on a large multicenter pediatric study
It uses objective laboratory values
It supports risk-based rather than one-size-fits-all management
It helps distinguish lower-risk infants from those needing more aggressive evaluation

How the Rule Fits With Modern Febrile Infant Pathways

In current pediatric practice, the PECARN rule is often used as one part of a broader febrile infant pathway. A clinician may first confirm that the infant is well appearing and otherwise appropriate for structured risk stratification, then obtain urine and blood studies, and then apply the PECARN low-risk criteria.

Depending on age and protocol, the result may help inform decisions about:

Lumbar puncture
Empiric antibiotics
Hospital admission
Observation in the emergency department
Outpatient follow-up in carefully selected cases

This is why the rule is best seen as a support tool within a clinical pathway rather than a stand-alone answer.

Strengths of the PECARN Rule

The PECARN Rule for Low Risk Febrile Infants has several strengths:

Objective criteria, based on measurable laboratory values
Good applicability to well-appearing infants
More modern biomarker use, including procalcitonin
Supports selective management
Helpful in reducing unnecessary invasive evaluation in some infants

These strengths make it one of the most important modern rules in young infant fever evaluation.

Limitations of the PECARN Rule

Like every prediction rule, PECARN has limitations.

It does not apply to every febrile infant
It is intended for well-appearing infants, not toxic or unstable infants
It relies on procalcitonin availability, which is not universal in all settings
It does not replace age-specific clinical management pathways
It does not mean risk is zero, even when criteria are met

Because of these limitations, the rule must always be used together with clinical judgment and local practice standards.

What If Procalcitonin Is Not Available

One practical issue is that not every hospital has rapid procalcitonin testing. In such settings, some institutions use alternate age-based febrile infant pathways or rely on guidance that substitutes other inflammatory markers. However, if the question is specifically whether an infant meets the PECARN low-risk rule, then procalcitonin is part of the classic rule and should not be silently omitted without acknowledging that a different approach is being used.

Clinical Judgment Still Matters

The PECARN rule is helpful, but it should not override the bedside clinical picture. A febrile infant who appears ill, unstable, poorly perfused, lethargic, or difficult to console may need aggressive management regardless of what a calculator shows. Similarly, an infant with significant prematurity, chronic illness, recent antibiotics, or abnormal social follow-up conditions may require a more cautious plan even if low-risk criteria are technically met.

That is why the rule is best used to support decisions, not replace them.

Who Uses a PECARN Febrile Infant Calculator

This calculator may be used by:

Emergency physicians
Pediatric emergency clinicians
Hospital pediatricians
Residents and medical trainees
Clinical teams standardizing febrile infant pathways

It is mainly intended for professional clinical use rather than unsupervised home decision-making.

Practical Tips for Accurate Use

Confirm that the infant is well appearing
Make sure the infant falls within the intended age range
Use a properly collected urine specimen for urinalysis
Check the ANC threshold carefully, 4090/µL or less
Use the correct procalcitonin cutoff, 1.71 ng/mL or less
Interpret the result within an age-specific febrile infant management framework

Educational Value of the PECARN Rule

The PECARN Rule for Low Risk Febrile Infants is also useful educationally because it teaches an important principle in infant fever evaluation: not all young febrile infants have the same risk profile, and objective data can help identify a subgroup at lower risk for serious bacterial infection. By combining urine testing with carefully chosen inflammatory markers, the rule helps clinicians move from a uniform approach toward a more structured, evidence-based risk assessment for infants 8 to 60 days old.